✦ LIBER ✦

Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonal antibody against EGFr (HuMax-EGFr) in patients with advanced squamous cell carcinoma of the head and neck

✍ Scribed by Lars Bastholt; Lena Specht; Kenneth Jensen; Eva Brun; Annika Loft; Jørgen Petersen; Helle Kastberg; Jesper G. Eriksen

Book ID: 118496940
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 172 KB
Volume: 85
Category: Article
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2007.06.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib and bevacizumab in patients wi

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study

✍ Ezra EW Cohen; Darren W Davis; Theodore G Karrison; Tanguy Y Seiwert; Stuart J W 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 442 KB

Ifosfamide, cisplatin, and 13-Cis retino

Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck : A Phase I–II study

✍ Francesco Recchia; Angelo Lalli; Marco Lombardo; Sandro De Filippis; Gaetano Sag 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 3 views

Phase II study of weekly high-dose cispl

Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck

✍ A.S.T. Planting; P.H.M. de Mulder; A. de Graeff; J. Verweij 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 694 KB

Evaluation of Gemcitabine in Patients wi

Evaluation of Gemcitabine in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Southwest Oncology Group Phase II Study

✍ Wolfram E. Samlowski; Holly Gundacker; J. Philip Kuebler; Jeffrey K. Giguere; Gl 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 68 KB

Phase I–II study with docetaxel (D), cis

Phase I–II study with docetaxel (D), cisplatin (C) and 5-fluorouracil (5-FU) in patients (pts) with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)

✍ D. Schrijvers; C. Van Herpen; J. Kerger; E. Joosens; C. Le Bouder; J. Castelijns 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Locoregional effects of pegylated liposo

Locoregional effects of pegylated liposomal doxorubicin (Caelyx®) in irradiated area: a phase I–II study in patients with recurrent squamous cell carcinoma of the head and neck

✍ Sandrine Faivre; Hassan Alsabe; Latifa Djafari; François Janot; Morbize Julieron 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 197 KB